Bristol-Myers Squibb (BMY) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $126.79B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | US | CEO | Christopher S. Boerner |
| IPO Date | 1972-06-01 | CAGR | 5% |
| Employees | 32,500 | Website | www.bms.com |
| Div. Yield | 1.93% | Payout Ratio | 70% |
| Buy Back Yield | 0.05% | Total Yield | 1.98% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| Enterprise Value | $170.08B | P/E Ratio | 10.47 |
| Forward P/E | 10.02 | PEG Ratio | 1.89 |
| P/S Ratio | 5.51 | P/B Ratio | 13.18 |
| P/CF Ratio | 19.95 | P/FCF Ratio | 22.28 |
| EPS | $5.93 | EPS Growth 1Y | 33.57% |
| EPS Growth 3Y | 3.79% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 1.78% | Gross Margin | 0.69% |
| Operating Margin | 0.26% | Profit Margin | 0.15% |
| ROE | 0.39% | ROA | 0.08% |
| ROCE | 0.18% | Current Ratio | 1.42 |
| Quick Ratio | 1.28 | Cash Ratio | 0.5 |
| Debt/Equity | 2.22 | Interest Coverage | 12.25 |
| Altman Z Score | 2.52 | Piotroski Score | 8 |
Bristol-Myers Squibb (BMY) valuation & financials
Bristol-Myers Squibb (BMY) has a market capitalization of $126.79B and trades at a price-to-earnings ratio of 10.5. It operates in the Healthcare sector (Drug Manufacturers - General).
Bristol-Myers Squibb's revenue grew +1.8% over the last year.
Bristol-Myers Squibb's next earnings report is scheduled for July 30, 2026 before market open; analysts estimate EPS of $1.61.
Bristol-Myers Squibb (BMY) — frequently asked questions
When does Bristol-Myers Squibb (BMY) report earnings next?
Bristol-Myers Squibb is expected to report earnings on July 30, 2026 before market open. Analysts estimate EPS of $1.61.
What is Bristol-Myers Squibb's market cap?
Bristol-Myers Squibb (BMY) has a market capitalization of $126.79B.
What is BMY's P/E ratio?
Bristol-Myers Squibb trades at a price-to-earnings ratio of 10.5, with trailing twelve-month EPS of $5.93.
How fast is Bristol-Myers Squibb growing?
Bristol-Myers Squibb's revenue grew +1.8% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)